AVXL R&D Expenses
Anavex Life Sciences Corp · R&D Expenses
AVXL R&D Expenses
Latest reported$4.14Mperiod ending
AVXL Quarterly R&D Expenses ($0.00 → $4.14M)
Quarterly R&D Expenses
High-resolution chart · PNG
AVXL r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 4,144,000 | |
| 4,192,000 | |
| 4,656,000 | |
| 7,294,000 | |
| 9,959,000 | |
| 9,892,000 | |
| 10,446,000 | |
| 11,555,000 | |
| 11,811,000 | |
| 9,729,000 | |
| 8,684,000 | |
| 10,060,636 | |
| 10,283,000 | |
| 10,557,000 | |
| 12,067,000 | |
| 11,381,450 | |
| 9,273,269 | |
| 8,604,589 | |
| 8,656,439 | |
| 9,372,786 | |
| 8,964,528 | |
| 6,720,841 | |
| 7,925,519 | |
| 6,104,906 | |
| 6,725,000 | |
| 6,053,047 | |
| 6,348,668 | |
| 4,710,907 | |
| 5,758,446 | |
| 6,078,786 | |
| 5,712,210 | |
| 4,407,452 | |
| 2,997,634 | |
| 3,245,023 | |
| 2,694,312 | |
| 3,836,386 | |
| 2,300,277 | |
| 2,492,933 | |
| 2,042,490 | |
| 4,338,871 | |
| 1,158,820 | |
| 1,090,527 | |
| 1,163,678 | |
| 746,503 | |
| 799,462 | |
| 407,146 | |
| 318,625 | |
| 344,048 | |
| 265,015 | |
| 118,152 | |
| 5,180 | |
| 97,263 | |
| 39,021 | |
| 560 | |
| 127,003 | |
| 112,957 | |
| 393,963 | |
| 429,607 | |
| 1,717,333 | |
| 591,776 | |
| 777,971 | |
| 730,242 | |
| 497,290 | |
| 1,088,587 | |
| 613,161 | |
| 815,609 | |
| 211,479 | |
| 1,071,148 | |
| 455,683 | |
| 328,859 | |
| 284,104 | |
| 784,534 | |
| 248,232 | |
| 223,566 | |
| 295,150 | |
| 894,202 | |
| 39,953 | |
| 25,543 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |